儿童及青年胶质瘤患者的SOX2免疫与组织驻留记忆T细胞
研究分析儿童胶质瘤中SOX2的表达及其免疫原性,发现SOX2在所有级别的儿童胶质瘤肿瘤细胞中表达而周围正常组织不表达,患者血液和肿瘤组织中可检测到针对SOX2的T细胞;胶质瘤富集CD8/CD4组织驻留记忆(TRM;CD45RO+、CD69+、CCR7-)表型T细胞,共表达PD-1、PD-L1和TIGIT等多个抑制性检查点,肿瘤还含有裂解性颗粒酶表达降低的自然杀伤细胞。
要点
- SOX2在儿童各等级胶质瘤肿瘤细胞中表达,而周围正常组织不表达。
- 胶质瘤患者血液和肿瘤组织中可检测到针对SOX2的T细胞。
- 胶质瘤富集CD8/CD4 TRM表型T细胞,共表达PD-1、PD-L1和TIGIT等抑制性检查点。
核心结论
- 数据表明SOX2具有免疫原性,在儿童胶质瘤肿瘤细胞上特异性过表达。
- 在胶质瘤中利用肿瘤免疫可能需要对多个抑制性检查点进行联合靶向。
研究设计与样本
- 研究检测了存档石蜡包埋儿童胶质瘤组织中SOX2的表达。
- 在儿童及青年胶质瘤患者的血液和肿瘤浸润T细胞中检测针对SOX2的T细胞免疫。
- 使用37标记面板的单细胞质谱流式分析肿瘤浸润免疫细胞的性质。
主要发现
- SOX2在所有级别的儿童胶质瘤肿瘤细胞中表达,而周围正常组织不表达。
- 胶质瘤患者血液和肿瘤组织中可检测到针对SOX2的T细胞。
- 胶质瘤富集CD8/CD4 T细胞,具有组织驻留记忆(TRM;CD45RO+、CD69+、CCR7-)表型,共表达PD-1、PD-L1和TIGIT等多个抑制性检查点。
- 肿瘤还含有裂解性颗粒酶表达降低的自然杀伤细胞。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapies targeting immune checkpoints are effective in tumors with a high mutation burden that express multiple neo-antigens. However, glial tumors including those seen in children carry fewer mutations and there is an unmet need to identify new antigenic targets of anti-tumor immunity. SOX2 is an embryonal stem cell antigen implicated in the biology of glioma initiating cells. Expression of SOX2 by pediatric glial tumors and the capacity of the immune system in these patients to recognize SOX2 has not been previously studied. We examined the expression of SOX2 on archived paraffin-embedded tissue from pediatric glial tumors. The presence of T-cell immunity to SOX2 was examined in both blood and tumor-infiltrating T-cells in children and young adults with glioma. The nature of tumor-infiltrating immune cells was analyzed with a 37-marker panel using single-cell mass cytometry. SOX2 is expressed by tumor cells but not surrounding normal tissue in pediatric gliomas of all grades. T-cells against this antigen can be detected in blood and tumor tissue in glioma patients. Glial tumors are enriched for CD8/CD4 T-cells with tissue resident memory (TRM; CD45RO+, CD69+, CCR7-) phenotype, which co-express multiple inhibitory checkpoints including PD-1, PD-L1 and TIGIT. Tumors also contain natural killer cells with reduced expression of lytic granzyme. Our data demonstrate immunogenicity of SOX2, which is specifically overexpressed on pediatric glial tumor cells. Harnessing tumor immunity in glioma will likely require the combined targeting of multiple inhibitory checkpoints.
引用
- Vasquez JC, Huttner A, Zhang L, et al. SOX2 immunity and tissue resident memory in children and young adults with glioma. J Neurooncol. 2017. PMID: 28620836. doi:10.1007/s11060-017-2515-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。